Reduction of Transplant Vasculopathy by Intraoperative Nucleic Acid-based Therapy in a Mouse Aortic Allograft Model.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 24 10 2018
medline: 18 12 2019
entrez: 24 10 2018
Statut: ppublish

Résumé

 Transplant vasculopathy (TV) is the main limiting factor for long-term graft survival characterized by fibrosis, myofibroblast, and smooth muscle cell (SMC) proliferation. Decoy oligodeoxynucleotide (dODN) against the transcription factor activator protein-1 (AP-1) might interfere with the expression of AV-related genes that govern neointima formation.  Aortic allografts from DBA/2 mice were incubated with control buffer, consensus, or mutated control AP-1 dODN and were transplanted into the infrarenal aorta of C57BL/6 mice. Cyclosporine A (10 mg/kg body weight [BW]) was administered daily. Explantation and histomorphometric and immunohistochemical evaluation was performed after 30 days. Matrix metalloproteinase (MMP) activity was visualized by gelatin in situ zymography.  Intima-to-media (I/M) ratio and neointima formation were significantly reduced in the consensus AP-1 dODN treatment group by 37% (  Intraoperative AP-1dODN utilization might be a strategy to preserve graft function after transplantation.

Sections du résumé

BACKGROUND BACKGROUND
 Transplant vasculopathy (TV) is the main limiting factor for long-term graft survival characterized by fibrosis, myofibroblast, and smooth muscle cell (SMC) proliferation. Decoy oligodeoxynucleotide (dODN) against the transcription factor activator protein-1 (AP-1) might interfere with the expression of AV-related genes that govern neointima formation.
METHODS METHODS
 Aortic allografts from DBA/2 mice were incubated with control buffer, consensus, or mutated control AP-1 dODN and were transplanted into the infrarenal aorta of C57BL/6 mice. Cyclosporine A (10 mg/kg body weight [BW]) was administered daily. Explantation and histomorphometric and immunohistochemical evaluation was performed after 30 days. Matrix metalloproteinase (MMP) activity was visualized by gelatin in situ zymography.
RESULTS RESULTS
 Intima-to-media (I/M) ratio and neointima formation were significantly reduced in the consensus AP-1 dODN treatment group by 37% (
CONCLUSION CONCLUSIONS
 Intraoperative AP-1dODN utilization might be a strategy to preserve graft function after transplantation.

Identifiants

pubmed: 30352477
doi: 10.1055/s-0038-1673633
doi:

Substances chimiques

Oligodeoxyribonucleotides 0
Transcription Factor AP-1 0
Matrix Metalloproteinases EC 3.4.24.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-512

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Rawa Arif (R)

Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Maximilian Franz (M)

Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Anca Remes (A)

Institute of Physiology and Pathophysiology, Heidelberg University, Heidelberg, Germany.

Marcin Zaradzki (M)

Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Markus Hecker (M)

Institute of Physiology and Pathophysiology, Heidelberg University, Heidelberg, Germany.

Matthias Karck (M)

Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Oliver J Müller (OJ)

Department of Internal Medicine III, University Hospital Kiel, Kiel, Germany.

Klaus Kallenbach (K)

Department of Cardiac Surgery, INCCI HaerzZenter, Luxembourg, Luxembourg.

Andreas H Wagner (AH)

Institute of Physiology and Pathophysiology, Heidelberg University, Heidelberg, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH